Crossmark

In vivo characterization of anti-atrial fibrillatory potential and pharmacological safety profile of INa,L plus IKr inhibitor ranolazine using the halothane-anesthetized dogs

Crossref DOI link: https://doi.org/10.1007/s00380-021-01830-1

Published Online: 2021-03-24

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nunoi, Yoshio

Kambayashi, Ryuichi

Goto, Ai

Hagiwara-Nagasawa, Mihoko

Chiba, Koki

Izumi-Nakaseko, Hiroko

Kawai, Shinichi

Takei, Yoshinori

Matsumoto, Akio

Watanabe, Yoshinori

Sugiyama, Atsushi
Funding

Funding for this research was provided by:

Japan Society for the Promotion of Science (20K16136, 19K16505)
License Information

Text and Data Mining valid from 2021-03-24

Version of Record valid from 2021-03-24
More Information

Article History

Received: 21 December 2020

Accepted: 5 March 2021

First Online: 24 March 2021

Declarations

:

: The authors declare no conflicts of interest.

Document is current

Any future updates will be listed below